MiR-423-3p enhances cell growth through inhibition of p21Cip1/Waf1 in colorectal cancer

Cellular Physiology and Biochemistry

Volumn 37, Issue 3, 2015, Pages 1044-1054

  Li, Hong Tao ^a   Zhang, Hui ^b   Chen, Yong ^a   Liu, Xian Fu ^a   Qian, Jun ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b Jiading District Central Hospital   (China)

Author keywords

Colorectal cancer; MiR 423 3p; P21Cip1 Waf1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MICRORNA; MICRORNA 423 3P; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MIRN423 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UPREGULATION; 3' UNTRANSLATED REGION; ANIMAL; CACO 2 CELL LINE; CANCER TRANSPLANTATION; CELL CYCLE; CELL LINE; CELL MOTION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; HT 29 CELL LINE; PATHOLOGY;

3' UNTRANSLATED REGIONS; ANIMALS; CACO-2 CELLS; CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION;

EID: 84942257220     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430230     Document Type: Article

References (30)

1. Ambros V: The functions of animal micrornas. Nature 2004; 431:350-355.
2. Sun K, Lai EC: Adult-specific functions of animal micrornas. Nat Rev Genet 2013; 14:535-548.
3. Shukla GC, Singh J, Barik S: Micrornas: Processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 2011; 3:83-92.
4. Bartel DP: Micrornas: Target recognition and regulatory functions. Cell 2009; 136:215-233.
5. Krol J, Loedige I, Filipowicz W: The widespread regulation of microrna biogenesis, function and decay. Nat Rev Genet 2010; 11:597-610.
6. Vincent K, Pichler M, Lee G.W., Ling H: Micrornas, genomic instability and cancer. Int J Mol Sci 2014; 15:14475-14491.
7. Adams BD, Kasinski AL, Slack FJ: Aberrant regulation and function of micrornas in cancer. Curr Biol 2014; 24:R762-776.
8. Garzon R, Calin GA, Croce CM: Micrornas in cancer. Annu Rev Med 2009; 60:167-179.
9. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29.
10. Torre LA, Bray F, Siegel R.L., Ferlay J., Lortet-Tieulent J, Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 2015
11. Zhang JH, Wang LH, Li X.J., Wang AP, Reng LQ, Xia FG, Yang Z.P., Jiang J., Wang XD, Wen CY: Expression of ang-2/tie-2 and pi3k/akt in colorectal cancer. Asian Pac J Cancer Prev 2014; 15:8651-8656.
12. Kalikaki A, Politaki H, Souglakos J., Apostolaki S, Papadimitraki E, Georgoulia N., Tzardi M, Mavroudis D, Georgoulias V., Voutsina A: Kras genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer. PLoS One 2014; 9:e104902.
13. Gu S, Honisch S, Kounenidakis M., Alkahtani S, Alarifi S, Alevizopoulos K., Stournaras C, Lang F: Membrane androgen receptor down-regulates c-src-activity and beta-catenin transcription and triggers gsk-3beta-phosphorylation in colon tumor cells. Cell Physiol Biochem 2014; 34:1402-1412.
14. Yan X, Shen H, Jiang H., Hu D, Wang J, Wu X: External qi of yan xin qigong inhibits activation of akt, erk1/2 and nf-kb and induces cell cycle arrest and apoptosis in colorectal cancer cells. Cell Physiol Biochem 2013; 31:113-122.
15. Zhu Y, Xia Y, Ye T., Shi X, Song X, Liu L., Zeng J, Wang N, Luo Y., Han Y, Yu L: A novel small-molecule ylt205 induces apoptosis in human colorectal cells via mitochondrial apoptosis pathway in vitro and inhibits tumor growth in vivo. Cell Physiol Biochem 2014; 33:933-944.
16. Towhid ST, Liu GL, Ackermann T.F., Beier N., Scholz W, Fuchss T, Toulany M., Rodemann HP, Lang F: Inhibition of colonic tumor growth by the selective sgk inhibitor emd638683. Cell Physiol Biochem 2013; 32:838-848.
17. Muhammad S, Kaur K, Huang R., Zhang Q, Kaur P, Yazdani H.O., Bilal MU, Zheng J, Zheng L, Wang XS: Micrornas in colorectal cancer: Role in metastasis and clinical perspectives. World J Gastroenterol 2014; 20:17011-17019.
18. Zhong M, Bian Z, Wu Z: Mir-30a suppresses cell migration and invasion through downregulation of pik3cd in colorectal carcinoma. Cell Physiol Biochem 2013; 31:209-218.
19. Sun D, Yu F, Ma Y., Zhao R, Chen X, Zhu J., Zhang CY, Chen J, Zhang J: Microrna-31 activates the ras pathway and functions as an oncogenic microrna in human colorectal cancer by repressing ras p21 gtpase activating protein 1 (rasa1). J Biol Chem 2013; 288:9508-9518.
20. Lin J, Huang S, Wu S., Ding J, Zhao Y, Liang L., Tian Q, Zha R, Zhan R., He X: Microrna-423 promotes cell growth and regulates g(1)/s transition by targeting p21cip1/waf1 in hepatocellular carcinoma. Carcinogenesis 2011; 32:1641-1647.
21. Boren T, Xiong Y, Hakam A., Wenham R, Apte S, Wei Z., Kamath S, Chen DT, Dressman H, Lancaster JM: Micrornas and their target messenger rnas associated with endometrial carcinogenesis. Gynecol Oncol 2008; 110:206-215.
22. Hui AB, Lenarduzzi M, Krushel T., Waldron L, Pintilie M, Shi W., Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, Gullane P., Cummings B, Liu FF: Comprehensive microrna profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16:1129-1139.
23. Sudoyo AW: A biomarker for metastatic colorectal cancer and treatment goals. Acta Med Indones 2014; 46:81-82.
24. Bates RC: Colorectal cancer progression: Integrin alphavbeta6 and the epithelial-mesenchymal transition (emt). Cell Cycle 2005; 4:1350-1352.
25. Bates RC, Mercurio AM: The epithelial-mesenchymal transition (emt) and colorectal cancer progression. Cancer Biol Ther 2005; 4:365-370.
26. el-Deiry W.S., Tokino T, Velculescu V.E., Levy DB, Parsons R, Trent JM, Lin D, Mercer W.E., Kinzler KW, Vogelstein B: Waf1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-825.
27. Cox LS: Multiple pathways control cell growth and transformation: Overlapping and independent activities of p53 and p21cip1/waf1/sdi1. J Pathol 1997; 183:134-140.
28. Liu M, Casimiro MC, Wang C, Shirley L.A., Jiao X., Katiyar S, Ju X, Li Z., Yu Z, Zhou J, Johnson M., Fortina P, Hyslop T, Windle J.J., Pestell RG: P21cip1 attenuates ras- and c-myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A 2009; 106:19035-19039.
29. Izawa H, Yamamoto H, Damdinsuren B., Ikeda K, Tsujie M, Suzuki R., Kitani K, Seki Y, Hayashi T., Takemasa I, Ikeda M, Ohue M., Sekimoto M, Monden T, Monden M: Effects of p21cip1/waf1 overexpression on growth, apoptosis and differentiation in human colon carcinoma cells. Int J Oncol 2005; 27:69-76.
30. Yamamoto H, Soh JW, Shirin H, Xing W.Q., Lim JT, Yao Y, Slosberg E, Tomita N., Schieren I, Weinstein IB: Comparative effects of overexpression of p27kip1 and p21cip1/waf1 on growth and differentiation in human colon carcinoma cells. Oncogene 1999; 18:103-115.